Back to Search Start Over

METastasis Reporting and Data System for Prostate Cancer as a Prognostic Imaging Marker in Castration-resistant Prostate Cancer

Authors :
Kazutaka Saito
Taro Takahara
Minato Yokoyama
Yuma Waseda
Yasuhisa Fujii
Yuki Arita
Chikako Ishii
Yoh Matsuoka
Toshiki Kijima
Soichiro Yoshida
Junichiro Ishioka
Source :
Clinical Genitourinary Cancer. 18:e391-e396
Publication Year :
2020
Publisher :
Elsevier BV, 2020.

Abstract

Background METastasis Reporting and Data System for Prostate Cancer (MET-RADS-P) has been proposed as a standard of data acquisition and interpretation for whole-body diffusion-weighted magnetic resonance imaging (WB-DWI) performed in men with advanced prostate cancer. The aim of this study is to demonstrate the clinical significance of the scores in castration-resistant prostate cancer (CRPC). Materials and Methods We retrospectively evaluated WB-DWI obtained from 72 patients with CRPC between 2014 and 2017, when disease progression was suspected at the time of starting a new line of anticancer therapy. Twenty-five (35%) and 30 (42%) patients had a treatment history that included taxane-based chemotherapy and new hormonal drugs, respectively. Results Active bone metastases were identified in 60 patients (83%; number of bone metastasis = 0, 1-2, 3-5, 6-10, and > 10: n = 12 [17%], 20 [28%], 11 [15%], 1 [1%], and 28 [39%], respectively). Progressive lymph node and visceral metastases were identified in 10 (14%) and 4 (6%), respectively. During the median follow-up period of 24 months, 36 (50%) died of prostate cancer. Cancer-specific survival (CSS) was significantly stratified according to the MET-RADS-P scores of osseous metastatic burden and the presence of visceral metastasis (P 10) and the presence of visceral metastasis were significant indicators of shorter CSS (P = .0036 and P = .0017, respectively). Conclusions The extent of bone metastasis and the presence of visceral metastasis on WB-DWI were associated with a shorter CSS in CRPC. MET-RADS-P score can be a prognostic imaging biomarker for CRPC.

Details

ISSN :
15587673
Volume :
18
Database :
OpenAIRE
Journal :
Clinical Genitourinary Cancer
Accession number :
edsair.doi.dedup.....11f3040a83419903a7a846572f426a18
Full Text :
https://doi.org/10.1016/j.clgc.2019.12.010